Qualitest issued a voluntary recall for 101 lots of hydrocodone bitartrate and acetaminophen tablets because some tablets could contain higher doses than marked and result in patient liver toxicity, according to the American Society of Anesthesiologists.
Recalled lots were distributed from Feb. 20 to Nov. 19 to wholesale distributors and national retail pharmacies.
Taking a higher dose of hydrocodone could increase severity or frequency of side effects, such as sedation or respiratory depression.
More Articles on Anesthesia:
Southern Medical Association Names Anesthesiologist President
Locale Anesthesia Conversion Factors Released From CMS
CareFusion Release Anesthesia Systems With More Patient Protections
Recalled lots were distributed from Feb. 20 to Nov. 19 to wholesale distributors and national retail pharmacies.
Taking a higher dose of hydrocodone could increase severity or frequency of side effects, such as sedation or respiratory depression.
More Articles on Anesthesia:
Southern Medical Association Names Anesthesiologist President
Locale Anesthesia Conversion Factors Released From CMS
CareFusion Release Anesthesia Systems With More Patient Protections